Michael A. Danso
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 36
- Cancer Treatment and Pharmacology 23
- HER2/EGFR in Cancer Research 18
- PARP inhibition in cancer therapy 8
-
- Advanced Breast Cancer Therapies 26
- Co-authors
- Clifford A. Hudis (4 shared papers)Ethan Basch (5 shared papers)Ashley S. Doane (2 shared papers)Priti Lal (2 shared papers)William L. Gerald (2 shared papers)Kari Bohlke (3 shared papers)Paul J. Hesketh (3 shared papers)Mark G. Kris (3 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Cancer Research (8 papers)Annals of Oncology (3 papers)ESMO Open (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Michael A. Danso
55 papers receiving 2.7k citations
Michael A. Danso's Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 1.3k
- Cancer Research 538
- Pulmonary and Respiratory Medicine 581
- Surgery 577
- Genetics 250
Countries citing papers authored by Michael A. Danso
This map shows the geographic impact of Michael A. Danso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Danso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Danso more than expected).
Fields of papers citing papers by Michael A. Danso
This network shows the impact of papers produced by Michael A. Danso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Danso. The network helps show where Michael A. Danso may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael A. Danso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 441 | |
| 2 | Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2017 | 405 |
| 3 | Antiemetics: ASCO Guideline Update Hit paper breakdown → | 2020 | 240 |
| 4 | 2014 | 231 | |
| 5 | 2014 | 195 | |
| 6 | 2011 | 191 | |
| 7 | 2015 | 154 | |
| 8 | 2019 | 90 | |
| 9 | 2010 | 70 | |
| 10 | 2017 | 58 | |
| 11 | VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2- advanced breast cancer Hit paper breakdown → | 2024 | 57 |
| 12 | 2013 | 49 | |
| 13 | 2015 | 43 | |
| 14 | 2011 | 37 | |
| 15 | 2018 | 35 | |
| 16 | 2023 | 32 | |
| 17 | 2021 | 30 | |
| 18 | 2021 | 30 | |
| 19 | 2016 | 30 | |
| 20 | 2024 | 28 |
About Michael A. Danso
Michael A. Danso is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Molecular Biology, having authored 60 papers that have together received 2.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (26 papers), Cancer Treatment and Pharmacology (23 papers), HER2/EGFR in Cancer Research (18 papers), Breast Cancer Treatment Studies (9 papers), PARP inhibition in cancer therapy (8 papers), Estrogen and related hormone effects (7 papers), BRCA gene mutations in cancer (6 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (538 citations), Pulmonary and Respiratory Medicine (581 citations), Surgery (577 citations) and Genetics (250 citations). Michael A. Danso has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Clifford A. Hudis, Ethan Basch, Ashley S. Doane, Priti Lal, William L. Gerald, Kari Bohlke, Paul J. Hesketh, Mark G. Kris, Gary H. Lyman and Rebecca Clark-Snow. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, ESMO Open and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.